A detailed history of Capital Management Associates, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Management Associates, Inc holds 830 shares of LLY stock, worth $746,128. This represents 0.16% of its overall portfolio holdings.

Number of Shares
830
Previous 414 100.48%
Holding current value
$746,128
Previous $320 Million 114.35%
% of portfolio
0.16%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$725.72 - $929.72 $301,899 - $386,763
416 Added 100.48%
830 $685 Million
Q4 2024

Jan 28, 2025

SELL
$727.2 - $932.06 $727 - $932
-1 Reduced 0.24%
414 $320 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.24%
415 $376 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $217,428 - $256,319
414 New
414 $241 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $854B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Management Associates, Inc Portfolio

Follow Capital Management Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates, Inc with notifications on news.